等待開盤 12-13 09:30:00 美东时间
-0.180
-2.07%
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Liberty Latin America shares are trading higher following a Q3 earnings beat.
11-07 01:24
Liberty Latin America (NASDAQ:LILA) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.06) by 133.33 percent. This is a 100.9 percent increase over losses of $(2.22) per share
11-06 06:16
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Liberty Global LiLAC ( ($LILA) ) just unveiled an update. Liberty Latin America...
10-30 05:17
Liberty Global LiLAC ( ($LILA) ) has provided an announcement. On September 23,...
09-25 21:19
-- Findings reinforce efficacy and tolerability profile in patients prescribed DAYBUE in the U.S. for as long as 12 months, consistent with the Phase 3 LAVENDER™ trial that supported FDA approval and open-label
09-13 04:07
(2025年8月28日,香港)国内一站式金属加工服务龙头企业——大明国际控股有限公司(“大明国际”或“公司”,股份代码:1090.HK)欣然宣布公司截至202...
08-29 09:10
Liberty Global LiLAC ( ($LILA) ) just unveiled an announcement. On August 8, 20...
08-15 05:17
Liberty Latin America (NASDAQ:LILA) reported quarterly losses of $(2.12) per share. This is a 863.64 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales
08-07 19:10